Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases.
Dohm AE, Nakashima JY, Kalagotla H, Jiang SX, Tang JD, Bhandari M, Kim Y, Graham JA, Khushalani NI, Forsyth PA, Etame AB, Liu JK, Tran ND, Vogelbaum MA, Wuthrick EJ, Yu HM, Oliver DE, Ahmed KA. Dohm AE, et al. Among authors: nakashima jy. Eur J Cancer. 2023 Oct;192:113287. doi: 10.1016/j.ejca.2023.113287. Epub 2023 Aug 7. Eur J Cancer. 2023. PMID: 37657227
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases.
Khatri VM, Mestres-Villanueva MA, Yarlagadda S, Doniparthi A, Smith DB, Nakashima JY, Bryant JM, Zhao D, Upadhyay R, Mills MN, Oliver DE, Yu HM, Palmer JD, Williams NO, Mahtani RL, Ahluwalia MS, Soliman HH, Han HS, Soyano AE, Kim Y, Kotecha R, Beyer SJ, Ahmed KA. Khatri VM, et al. Among authors: nakashima jy. NPJ Breast Cancer. 2024 Nov 21;10(1):100. doi: 10.1038/s41523-024-00711-w. NPJ Breast Cancer. 2024. PMID: 39572568 Free PMC article.
Tumor burden quantified by Soluble B-Cell Maturation Antigen and Metabolic Tumor Volume determine myeloma CAR-T outcomes.
Freeman CL, Noble J, Menges M, Villanueva R, Nakashima JY, Figura NB, Tonseth RP, Idiaquez DW, Skelson L, Smith EC, Abraham-Miranda J, Corallo S, De Avila G, Castaneda Puglianini O, Liu HD, Alsina M, Nishihori T, Shain KH, Baz RC, Blue BJ, Grajales-Cruz A, Koomen JM, Atkins RM, Hansen DK, Siqueira Silva A, Kim J, Balagurunathan Y, Locke FL. Freeman CL, et al. Among authors: nakashima jy. Blood. 2024 Dec 9:blood.2024024965. doi: 10.1182/blood.2024024965. Online ahead of print. Blood. 2024. PMID: 39652773
Impact of Myc-Altered Pathology on Radiation Therapy Efficacy Among Patients With Relapsed/Refractory Large-B Cell Lymphoma: A Collaborative Study by ILROG.
Tseng YD, Stevenson P, Nguyen B, Li DC, Lee DY, Paydar I, Nakashima J, Balogh A, Ravella R, Barbour AB, Post C, Ababneh H, Pinnix CC, Ballas LK, Binkley MS, Dedeckova K, Hoppe RT, Patel C, Nabavizadeh N, Kelsey CR, Kumar KA, Landsburg D, Figura NB, Lo AC, Plastaras JP. Tseng YD, et al. Int J Radiat Oncol Biol Phys. 2024 Nov 15:S0360-3016(24)03642-3. doi: 10.1016/j.ijrobp.2024.11.072. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39549763